Bowling Portfolio Management LLC reduced its stake in Aetna Inc (NYSE:AET) by 1.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 23,732 shares of the company’s stock after selling 282 shares during the quarter. Aetna accounts for 0.7% of Bowling Portfolio Management LLC’s investment portfolio, making the stock its 23rd largest position. Bowling Portfolio Management LLC’s holdings in Aetna were worth $4,814,000 as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of the company. FMR LLC lifted its holdings in shares of Aetna by 3.5% in the 2nd quarter. FMR LLC now owns 7,734,487 shares of the company’s stock worth $1,419,279,000 after acquiring an additional 261,463 shares during the last quarter. Northern Trust Corp lifted its holdings in Aetna by 0.8% during the 2nd quarter. Northern Trust Corp now owns 3,803,810 shares of the company’s stock worth $697,999,000 after buying an additional 28,520 shares in the last quarter. PointState Capital LP lifted its holdings in Aetna by 111.2% during the 2nd quarter. PointState Capital LP now owns 2,193,062 shares of the company’s stock worth $402,427,000 after buying an additional 1,154,818 shares in the last quarter. Summit Trail Advisors LLC lifted its holdings in Aetna by 55,803.4% during the 1st quarter. Summit Trail Advisors LLC now owns 1,616,727 shares of the company’s stock worth $1,617,000 after buying an additional 1,613,835 shares in the last quarter. Finally, Abrams Capital Management L.P. lifted its holdings in Aetna by 14.1% during the 2nd quarter. Abrams Capital Management L.P. now owns 1,575,000 shares of the company’s stock worth $289,013,000 after buying an additional 195,000 shares in the last quarter. Hedge funds and other institutional investors own 83.49% of the company’s stock.
A number of research firms have issued reports on AET. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $228.00 target price on the stock in a report on Thursday, October 4th. Cantor Fitzgerald lowered shares of Aetna from an “overweight” rating to a “neutral” rating and set a $202.00 target price on the stock. in a report on Wednesday, August 22nd. Finally, ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a report on Tuesday, June 26th. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Aetna presently has a consensus rating of “Hold” and a consensus target price of $203.77.
Aetna (NYSE:AET) last announced its quarterly earnings data on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.04 by $0.39. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The business had revenue of $15.56 billion for the quarter, compared to analyst estimates of $15.59 billion. During the same period last year, the business earned $3.42 EPS. The company’s revenue was up .2% on a year-over-year basis. On average, analysts predict that Aetna Inc will post 11.31 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be issued a $0.50 dividend. The ex-dividend date is Tuesday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.99%. Aetna’s payout ratio is 20.28%.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Featured Story: Leveraged Buyout (LBO) Explained
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.